Tag: Chemotherapy
Brain Functional Networks Affected by Neoadjuvant Chemo in Breast Cancer
Increased global efficiency, as well as decreased characteristic path length and altered nodal centralities, seen on functional MRI
ASTRO Issues Clinical Guideline for Use of Radiation Therapy in Anal Cancer
For most patients, definitive treatment with combined modality therapy is recommended
Chemo Tied to Long-Lasting Physical Health Decline for Breast Cancer Survivors
Physical health decline greater for survivors receiving chemotherapy compared with endocrine therapy alone within two years of diagnosis
Nivolumab Added to Chemo Improves Response in ER+, HER2− Breast Cancer
Adding nivolumab to neoadjuvant chemotherapy significantly increases pathological complete response rates
Dual-Targeted Therapies Plus Chemo Improve Objective Response Rate in BRAF V600E Metastatic CRC
Significant and clinically relevant improvement seen in objective response rate with encorafenib + cetuximab plus mFOLFOX6
Four in 10 Patients Receiving Chemo Develop Chronic Painful Neuropathy
Among patients with chemotherapy-induced peripheral neuropathy, those treated with platinum-based agents, taxanes had highest prevalence
Perioperative Chemo With FLOT Ups Survival in Resectable Esophageal Cancer
Improved survival seen with perioperative chemotherapy with FLOT versus preoperative chemoradiotherapy
Glucarpidase Improves Outcomes in Patients With Methotrexate-Induced Kidney Toxicity
Glucarpidase associated with 2.70-fold increased odds of kidney recovery in methotrexate-acute kidney injury
Platinum Chemo Shortage Led to Reduced Use, No Change in Mortality
Modest absolute reduction in use observed, which increased during peak of shortage; no difference seen in mortality during shortage
SABCS: Adding Camrelizumab to Neoadjuvant Chemo Beneficial in TNBC
Addition of camrelizumab improves pathological complete response in early or locally advanced triple negative breast cancer
